Lorundrostat

Cat. No. M49422

All AbMole products are for research use only, cannot be used for human consumption.

Size	Price	Availability
5mg	USD 185 USD185	In stock
10mg	USD 280 USD280	In stock
25mg	USD 500 USD500	In stock
50mg	USD 750 USD750	In stock

Free Delivery on orders over USD 500 Bulk Inquiry?

Lorundrostat is an aldosterone synthase inhibitor and is used in the research related to hypertension.

Molecular Weight	451.56
Formula	C24H33N7O2
CAS Number	1820940-17-7
Form	Solid
Solubility (25°C)	DMSO 30 mg/mL
Storage	Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month

Related Mineralocorticoid Receptor Products
Spironolactone Spironolactone (SC9420) is an oral active aldosterone mineralocorticoid receptor antagonist with an IC50 value of 24 nM. Spironolactone is also an androgen receptor antagonist with an IC50 of 77 nM. Spironolactone promotes podocyte autophagy.
Potassium canrenoate Canrenoate potassium is a predrug for the release of Canrenone and an effective antagonist of competitive salt ocorticoid receptor. As a diuretic, Canrenoate potassium is used in the study of hypertension.
Osilodrostat Osilodrostat (LCI699) is a potent, orally active11β-hydroxylase (CYP11B1) inhibitor with an IC50 value of 35 nM. Osilodrostat is a potent, orally aldosterone synthase (CYP11B2) inhibitor with IC50 values of 0.7 nM and 160 nM for human aldosterone synthase and rat aldosterone synthase, respectively.
Canrenone Canrenone is a mineralocorticoid receptor antagonist.
Finerenone Finerenone (BAY 94-8862) is a third generation selective, oral active, non-steroidal halocorticoid receptor (MR) antagonist (IC50=18 nM). Finerenone showed good selectivity (>500-fold) compared to glucocorticoid receptor (GR), androgen receptor (AR), and progesterone receptor (AR). Finerenone has potential applications in the study of heart and kidney diseases, such as type 2 diabetes and chronic kidney disease.

Catalog